Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Changzhou Qianhong Biopharma Co Ltd
Revenue
Changzhou Qianhong Biopharma Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
|
Revenue
¥1.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥10.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥23.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Revenue
¥561.9m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Changzhou Qianhong Biopharma Co Ltd's Revenue?
Revenue
1.7B
CNY
Based on the financial report for Mar 31, 2024, Changzhou Qianhong Biopharma Co Ltd's Revenue amounts to 1.7B CNY.
What is Changzhou Qianhong Biopharma Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%
Over the last year, the Revenue growth was -29%. The average annual Revenue growth rates for Changzhou Qianhong Biopharma Co Ltd have been -4% over the past three years , 4% over the past five years , and 7% over the past ten years .